[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE68903907D1 - Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. - Google Patents

Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.

Info

Publication number
DE68903907D1
DE68903907D1 DE8989308901T DE68903907T DE68903907D1 DE 68903907 D1 DE68903907 D1 DE 68903907D1 DE 8989308901 T DE8989308901 T DE 8989308901T DE 68903907 T DE68903907 T DE 68903907T DE 68903907 D1 DE68903907 D1 DE 68903907D1
Authority
DE
Germany
Prior art keywords
production
cyclic peptide
cardiovascular disorders
treating cardiovascular
hapsidospora
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989308901T
Other languages
English (en)
Other versions
DE68903907T2 (de
Inventor
Kiyoshi C O Sankyo Comp Hamano
Kouhei C O Sankyo Compa Furuya
Kazuhiko C O Sankyo Co Tanzawa
Takeshi C O Sankyo Co Kagasaki
Masaaki C O Sankyo Co Miyamoto
Takeshi C O Sankyo C Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE68903907D1 publication Critical patent/DE68903907D1/de
Application granted granted Critical
Publication of DE68903907T2 publication Critical patent/DE68903907T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8989308901T 1988-09-05 1989-09-01 Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. Expired - Fee Related DE68903907T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22196088 1988-09-05

Publications (2)

Publication Number Publication Date
DE68903907D1 true DE68903907D1 (de) 1993-01-28
DE68903907T2 DE68903907T2 (de) 1993-06-09

Family

ID=16774855

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989308901T Expired - Fee Related DE68903907T2 (de) 1988-09-05 1989-09-01 Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.

Country Status (6)

Country Link
US (1) US5112807A (de)
EP (1) EP0358418B1 (de)
AT (1) ATE83480T1 (de)
DE (1) DE68903907T2 (de)
ES (1) ES2054011T3 (de)
GR (1) GR3007079T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US5461070A (en) * 1994-08-29 1995-10-24 The Regents Of The University Of California Anti-flammatory method using indole alkaloids
SI2376101T1 (sl) 2008-12-29 2016-02-29 Trevena, Inc. Efektorji beta-arestina in sestavki ter metode za njihovo uporabo
JP6225121B2 (ja) * 2012-01-31 2017-11-01 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． β−アレスチンエフェクターおよび組成物ならびにそれらの使用方法
US9518086B2 (en) 2014-02-07 2016-12-13 Trevena, Inc. Crystalline and amorphous forms of a β-arrestin effector
CN106456698B (zh) 2014-05-19 2022-05-17 特维娜有限公司 β-抑制蛋白效应物的合成
CN106892875B (zh) * 2016-11-11 2018-03-02 杭州唯铂莱生物科技有限公司 钙离子通道阻滞剂化合物及其制备方法和应用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108106B (en) * 1978-07-04 1983-09-01 Shell Int Research Novel macrocyclic compounds and salts thereof useful for dissolving barium sulphate scale
SU1219587A1 (ru) * 1978-09-29 1986-03-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Циклические аналоги каллидина и других пахикининов,обладающие пролонгированным гипотензивным действием в сочетании с низкой или полностью отсутствующей миотропной активностью

Also Published As

Publication number Publication date
US5112807A (en) 1992-05-12
ES2054011T3 (es) 1994-08-01
GR3007079T3 (de) 1993-07-30
EP0358418A1 (de) 1990-03-14
DE68903907T2 (de) 1993-06-09
EP0358418B1 (de) 1992-12-16
ATE83480T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
DE69201948D1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE210653T1 (de) Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen
DE68929563D1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension
DE69120500D1 (de) Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung
ATE88894T1 (de) Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.
ATE218864T1 (de) Verwendung von piperidin-derivaten in der behandlung von schizophrenie
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE78031T1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE82327T1 (de) Neues herbizid, seine herstellung und seine verwendung.
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE86960T1 (de) Cyclopropanderivate.
ATE94882T1 (de) Heparinbindende gehirnmitogene.
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE68906248D1 (de) Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.
ATE136217T1 (de) Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks
DE3868302D1 (de) Aether und thioaether mit heilender wirkung, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE69268T1 (de) Verfahren zur herstellung von 4-androsten-3, 17- dion und 1,4-androstadien-3,17-dion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee